IDiyas

For the Inventor, By the Inventor

Hofheim am Taunus, Germany

Klaus U Weithmann

USPTO Granted Patents = 19

Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 135(Granted Patents)


Location History:

  • Eppstein, DE (1982)
  • Hofheim, DE (1996 - 1998)
  • Hofheim am Taunus, DE (1987 - 2000)

Company Filing History:

goldMedal16 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents
silverMedal1 out of 1 
 
Hoechst Aktienegesellschaft
 patent
bronzeMedal1 out of 3 
 
Hoechst Aktiengesllschaft
 patents
4. 1 out of 15 
 
Hoeschst Aktiengesellschaft
 patents
5. 1 out of 539 
 
Hoechst Roussel Pharmaceuticals
 patents
where one patent can have more than one assignee

Years Active: 1982-2000

Loading Chart...
19 patents (USPTO):Explore Patents
1. 6159988 - Arylcycloalkyl derivatives, their production and their use (2000-12-12),
2. 5814627 - 3, 5-disubstituted and 3, 4, 5-trisubstituted 2-isoxazolines and (1998-09-29),
3. 5776977 - Arylcycloalkyl derivatives, their production and their use (1998-07-07),
4. 5627173 - Phosphonoacetic acid derivatives and their use for treating degenerative (1997-05-06),
5. 5589514 - Arylcycloalkyl derivatives, their production and their use (1996-12-31),
6. 5556870 - Use of leflunomide for inhibiting interleukin 1 beta (1996-09-17),
7. 5554637 - Use of leflunomide for inhibiting interleukin 1 alpha (1996-09-10),
8. 5547971 - Use of leflunomide for inhibiting interleukin 8 (1996-08-20),
9. 5547970 - Use of leflunomide for inhibiting tumor necrosis factor alpha (1996-08-20),
10. 5504084 - Pharmaceutical for the treatment of skin disorders (1996-04-02),
11. 5137897 - 2-substituted 4-(3-alkyl-5-tert.-butyl-4-hydroxyphenyl) thiazoles, (1992-08-11),
12. 5043328 - Formulations containing unsaturated fatty acids for the synthesis of (1991-08-27),
13. 4983514 - Method for detecting the antiaggregatory effect of vasoactive (1991-01-08),
14. 4975432 - Method of using pentoxifylline for treating inflammation (1990-12-04),
15. 4904648 - Pharmaceutical preparations for induction of labor and for contraceptive (1990-02-27),

Title: Klaus U. Weithmann: A Pioneer in Pharmaceutical Innovations

Introduction

Klaus U. Weithmann is a distinguished inventor located in Hofheim am Taunus, Germany. With an impressive portfolio of 19 patents, he has significantly contributed to the field of pharmaceuticals. His innovations focus on compounds that show promising activities against various inflammatory conditions.

Latest Patents

Among Klaus's latest patents is a noteworthy invention involving Arylcycloalkyl derivatives, including their production and use. The compounds, defined by specific formula I, have been discovered to possess activity against inflammatory conditions. Additionally, he has developed 3, 5-disubstituted and 3, 4, 5-trisubstituted 2-isoxazolines, which further emphasize his expertise in creating vital pharmaceutical compounds.

Career Highlights

Throughout his career, Klaus has made significant strides in the pharmaceutical industry. He has worked with reputable companies such as Hoechst Aktiengesellschaft, a prominent player in the field of healthcare and pharmaceuticals. His work at these institutions has allowed him to harness his innovative potential and bring impactful inventions to fruition.

Collaborations

Klaus has had the privilege to collaborate with several notable coworkers, including Robert R. Bartlett and Dirk Seiffge. These collaborations have likely enabled the exchange of ideas and expertise, further enhancing the quality and reach of his inventions.

Conclusion

Klaus U. Weithmann stands out as a pivotal figure in pharmaceutical innovation, with a focus on creating compounds that address pressing health issues. His extensive patent portfolio and collaborations signify his dedication to advancing medical science and improving patient care through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…